Further exploration revealed that SEMA3B competitively inhibited vascular endothelial growth factor (VEGF) signaling pathway activation by binding to the NRP1 receptor, thus suppressing the invasion and metastasis of CRC. This evidence concerns the gene VEGFA and colorectal carcinoma.